Social and Psychological Impacts of SARS-Cov-2 Pandemic Period in the Obese Population.
NCT ID: NCT04910607
Last Updated: 2024-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
279 participants
OBSERVATIONAL
2022-01-21
2023-07-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Other risk factors, such as social-environmental factors, must be taken into consideration. Socio-demographic surveys in this area highlight the socio-economic and territorial inequalities that interfere with obesity issues. Similarly, the issues of stigmatisation and isolation seem to be at the heart of the question of how to deal with these people.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Obesity and Mortality of Critically Ill Patients With COVID-19
NCT04425213
Association Between BMI and COVID-19
NCT04391738
Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19
NCT05771857
Impact of Adipose Tissue in COVID-19
NCT04639440
Study of the Intestinal Microbiota During a Real Life Dietary Intervention in Subjects With Overweight or Obesity
NCT04822948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The medical and paramedical staff involved in the partner CSOs and the patients' resources (identified by the patients' associations) will also be asked to participate in a semi-directive interview.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient
Participating patients will be recruited from the Specialised Obesity Centres =CSO (CHU and Follow-up and rehabilitation care (SSR), as well as patient associations) to fill in a questionnaire and take part in an interview (varied panel representative of the target population in terms of place of residence, socio-professional category, sex and age).
Questionnaire
Questionnaire with 4 axes:
sociological, reflexive medical, prospective medical, transversal
Interview
Interview concerning health pathways, experience of confinement, consequences of confinement on health, representations of obesity.
Professional
Medical and paramedical staff involved in the partner CSOs will also be asked to participate in a semi-structured interview.
Interview
Interview concerning health pathways, experience of confinement, consequences of confinement on health, representations of obesity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
Questionnaire with 4 axes:
sociological, reflexive medical, prospective medical, transversal
Interview
Interview concerning health pathways, experience of confinement, consequences of confinement on health, representations of obesity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be registered in an active file of the 3 partner CSOs.
Exclusion Criteria
* Patients under protective measures or deprived of liberty:
* pregnant or breastfeeding woman,
* under guardianship,
* under guardianship,
* safeguard of justice,
* incarcerated.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Région Nouvelle Aquitaine
UNKNOWN
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arnaud ALESSANDRIN, Dr
Role: STUDY_CHAIR
Universite de Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Limoges
Limoges, , France
Hôpital Haut-Lévêque
Pessac, , France
CHU de Poitiers
Poitiers, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2020/38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.